Effects of combined SGLT2 inhibitor and DPP-4 inhibitor therapy on advanced glycation end products - Trial UMIN000049408

Name: Clinical Trial UMIN000049408
Creator: Akishima Clinic
Keywords: Type 2 diabetes, drug, clinical trial, Japan

Access comprehensive clinical trial information for UMIN000049408 through Pure Global AI's free database. This phase not specified trial is sponsored by Akishima Clinic and is currently Completed. The study focuses on Type 2 diabetes.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

UMIN000049408

Completed

drug

Trial Details

University Hospital Medical Information Network • UMIN000049408

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Effects of combined SGLT2 inhibitor and DPP-4 inhibitor therapy on advanced glycation end products

Study Focus

Disease/Condition

Type 2 diabetes

Study Type

Interventional

Intervention Type

drug

Sponsor & Location

Primary Sponsor

Akishima Clinic

Location

Japan

Timeline & Enrollment

Phase

N/A

Start Date

Oct 21, 2020

End Date

N/A

ICD-10 Classifications

Type 2 diabetes mellitus

Type 2 diabetes mellitus without complications

Type 2 diabetes mellitus with unspecified complications

Type 2 diabetes mellitus with other specified complications

Type 2 diabetes mellitus with multiple complications

Data Source

Registry

University Hospital Medical Information Network

Trial ID

UMIN000049408

Type

Non-Device Trial